Association of change in haemoglobin A1c with adverse perinatal outcomes in women with pregestational diabetes. Issue 7 (8th March 2022)

• Record Type: Journal Article
• Authors: Kiefer, Miranda K.; Finneran, Matthew M.; Ware, Courtney A.; Fareed, Naleef; Joseph, Joshua; Thung, Stephen F.; Costantine, Maged M.; Landon, Mark B.; Gabbe, Steven G.; Venkatesh, Kartik K.
• Is Part Of: Diabetic medicine. Volume 39:Issue 7(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-03-08
• Subjects: complications -- diabetes -- diabetes mellitus -- glycosylated haemoglobin -- haemoglobin A1c -- pregestational diabetes -- pregnancy; Diabetes -- Periodicals; 616.462
• DOI: 10.1111/dme.14822
• Languages: English
• ISSNs: 0742-3071

Abstract

Abstract: Aims: To determine whether a net decline in glycosylated haemoglobin (HbA1c ) from early to late pregnancy is associated with lower risk of adverse perinatal outcomes at delivery among women with pregestational diabetes. Methods: A retrospective analysis from 2012 to 2016 at a tertiary care centre. The exposure was the net change in HbA1c from early (<20 weeks gestation) to late pregnancy (≥20 weeks gestation). Primary outcomes were large for gestational age (LGA) and neonatal hypoglycaemia. The association between outcomes per 6 mmol/mol (0.5%) absolute decrease in HbA1c was evaluated using modified Poisson regression, and adjusted for age, body mass index, White Class, early HbA1c and haemoglobin and gestational age at HbA1c measurement and delivery. Results: Among 347 women with pregestational diabetes, HbA1c was assessed in early (9 weeks [IQR 7, 13]) and late pregnancy (31 weeks [IQR 29, 34]). Mean HbA1c decreased from early (59 mmol/mol [7.5%]) to late (47 mmol/mol [6.5%]) pregnancy. Each 6 mmol/mol (0.5%) absolute decrease in HbA1c was associated with a 12% reduced risk of LGA infant (30%, aRR:0.88; 95% CI:0.81, 0.95), and a 7% reduced risk of neonatal hypoglycaemia (35%, aRR:0.93; 95% CI:0.87, 0.99). Preterm birth (36%, aRR:0.93; 95% CI:0.89, 0.98) and neonatal intensive care unit admission (55%, aRR:0.95; 95% CI:0.91, 0.98) decreased with a net decline in HbA1c, but not caesarean delivery, pre‐eclampsia, shoulder dystocia and respiratory distress syndrome. Conclusions: Women with pregestational diabetes with a reduction in HbA1c may have fewer infants born LGA or with neonatal hypoglycaemia. Repeated assessment of HbA1c may provide an additional measure of glycaemic control.